Status:
WITHDRAWN
Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC
Lead Sponsor:
Fertilys
Collaborating Sponsors:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Infertility, Female
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to identify a systemic immunological profile specific to patients with recurrent implantation failures (RIF) or miscarriages (RM) through blood immunophenotyping on the da...
Eligibility Criteria
Inclusion
- All women aged 18 and over undergoing an IVF cycle with her partner's sperm at the Fertilys fertility center, without a RIF status, agreeing to participate in the study and having signed the consent form to participate in the study.
- All women aged 18 and over undergoing an IVF cycle with her partner's sperm at the Fertilys fertility center, with a RIF or RM status, agreeing to participate in the study and having signed the consent form to participate in the study.
Exclusion
- Women who need a gametes donor (eggs and / or sperm).
- Women undergoing an IVF cycle with frozen sperm.
- Women with autoimmune disease.
- Women with diabetes.
- Women with a history of chemotherapy treatment.
Key Trial Info
Start Date :
September 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04753736
Start Date
September 24 2021
End Date
November 1 2021
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fertilys
Laval, Quebec, Canada, H7S1Z5